| Dr Oladunni T Filani, MD | |
|
4201 Mitchellville Rd Ste 102, Bowie, MD 20716-3175 | |
| (301) 262-5900 | |
| Not Available |
| Full Name | Dr Oladunni T Filani |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 23 Years |
| Location | 4201 Mitchellville Rd Ste 102, Bowie, Maryland |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235468968 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Howard University Hospital | Washington, DC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Maryland Primary Care Physicians, Llc | 8729981832 | 91 |
News Archive
No clear split between conservative and liberal Supreme Court justices emerged Tuesday as justices heard arguments over whether the federal government could renege on Congress' promise to pay health insurance companies billions to motivate them to participate in the Obamacare marketplaces.
A recent Children's Oncology Group study identified a treatment algorithm that can help reduce therapy for some neuroblastoma patients with intermediate-risk disease, while maintaining good clinical outcomes.
Biocartis SA, a biotech company active in the field of personalized medicine and focused on fast, multiplexed and fully integrated molecular diagnostics based on its proprietary micro-technology and sample preparation platforms, today announced the successful closing of a Series B equity financing round. The Company raised EUR 30 million (~ USD 41.3 million) from its current shareholder base of leading life science investors and two new strategic investors from the pharmaceutical/diagnostic industry.
Researchers at Wake Forest Baptist Medical Center have made a discovery that brings them one step closer to being able to better predict which patients have the best chance of surviving breast cancer.
› Verified 7 days ago
| Entity Name | Howard University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033163597 PECOS PAC ID: 0941109565 Enrollment ID: O20040102000561 |
News Archive
No clear split between conservative and liberal Supreme Court justices emerged Tuesday as justices heard arguments over whether the federal government could renege on Congress' promise to pay health insurance companies billions to motivate them to participate in the Obamacare marketplaces.
A recent Children's Oncology Group study identified a treatment algorithm that can help reduce therapy for some neuroblastoma patients with intermediate-risk disease, while maintaining good clinical outcomes.
Biocartis SA, a biotech company active in the field of personalized medicine and focused on fast, multiplexed and fully integrated molecular diagnostics based on its proprietary micro-technology and sample preparation platforms, today announced the successful closing of a Series B equity financing round. The Company raised EUR 30 million (~ USD 41.3 million) from its current shareholder base of leading life science investors and two new strategic investors from the pharmaceutical/diagnostic industry.
Researchers at Wake Forest Baptist Medical Center have made a discovery that brings them one step closer to being able to better predict which patients have the best chance of surviving breast cancer.
› Verified 7 days ago
| Entity Name | Maryland Primary Care Physicians, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083667067 PECOS PAC ID: 8729981832 Enrollment ID: O20050913001224 |
News Archive
No clear split between conservative and liberal Supreme Court justices emerged Tuesday as justices heard arguments over whether the federal government could renege on Congress' promise to pay health insurance companies billions to motivate them to participate in the Obamacare marketplaces.
A recent Children's Oncology Group study identified a treatment algorithm that can help reduce therapy for some neuroblastoma patients with intermediate-risk disease, while maintaining good clinical outcomes.
Biocartis SA, a biotech company active in the field of personalized medicine and focused on fast, multiplexed and fully integrated molecular diagnostics based on its proprietary micro-technology and sample preparation platforms, today announced the successful closing of a Series B equity financing round. The Company raised EUR 30 million (~ USD 41.3 million) from its current shareholder base of leading life science investors and two new strategic investors from the pharmaceutical/diagnostic industry.
Researchers at Wake Forest Baptist Medical Center have made a discovery that brings them one step closer to being able to better predict which patients have the best chance of surviving breast cancer.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Oladunni T Filani, MD 7580 Buckingham Blvd Ste 220, Hanover, MD 21076-3210 Ph: (410) 729-5100 | Dr Oladunni T Filani, MD 4201 Mitchellville Rd Ste 102, Bowie, MD 20716-3175 Ph: (301) 262-5900 |
News Archive
No clear split between conservative and liberal Supreme Court justices emerged Tuesday as justices heard arguments over whether the federal government could renege on Congress' promise to pay health insurance companies billions to motivate them to participate in the Obamacare marketplaces.
A recent Children's Oncology Group study identified a treatment algorithm that can help reduce therapy for some neuroblastoma patients with intermediate-risk disease, while maintaining good clinical outcomes.
Biocartis SA, a biotech company active in the field of personalized medicine and focused on fast, multiplexed and fully integrated molecular diagnostics based on its proprietary micro-technology and sample preparation platforms, today announced the successful closing of a Series B equity financing round. The Company raised EUR 30 million (~ USD 41.3 million) from its current shareholder base of leading life science investors and two new strategic investors from the pharmaceutical/diagnostic industry.
Researchers at Wake Forest Baptist Medical Center have made a discovery that brings them one step closer to being able to better predict which patients have the best chance of surviving breast cancer.
› Verified 7 days ago
Emma Rebecca Williams, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 17001 Science Dr, Suite 102, Bowie, MD 20715 Phone: 240-556-1000 | |
Dr. Rakesh Arora, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 14300 Gallant Fox Ln, Suite 222, Bowie, MD 20715 Phone: 301-262-7800 Fax: 301-805-0782 | |
Dr. Paul David Giles, DO, MS Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 17001 Science Dr Ste 102, Bowie, MD 20715 Phone: 240-556-1000 | |
Dr. Tahani Laila Williams, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 13108 Hunters Ridge Ln, Bowie, MD 20721 Phone: 301-332-9986 | |
Dr. Sonia Marie Rhoden-salmon, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 15459 Annapolis Rd, Bowie, MD 20715 Phone: 240-544-0676 | |
Mariama Jeloh Bah-sow, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 17001 Science Dr Ste 102, Bowie, MD 20715 Phone: 240-556-1000 | |
Dr. Konni Elaine Bringman, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 4201 Mitchellville Rd, Suite 102, Bowie, MD 20716 Phone: 301-262-5900 Fax: 410-741-0865 |